Validation and Limitations of Use of a Breast Cancer Nomogram Predicting the Likelihood of Non–Sentinel Node Involvement After Positive Sentinel Node Biopsy
- 9 February 2007
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 14 (8), 2195-2201
- https://doi.org/10.1245/s10434-006-9331-2
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patientsCancer, 2003
- Histological Detection of Minimal Metastatic Involvement in Axillary Sentinel Nodes: A Rational Basis for a Sensitive Methodology Usable in Daily PracticeLaboratory Investigation, 2002
- Sentinel Lymph Node Detection for Breast Cancer: Which Patients Are Best Suited for the Patent Blue Dye Only Method of Identification?Annals of Surgical Oncology, 2001
- Ganglion sentinelle et cancer opérable du sein : utilisation du bleu patent. Étude piloteAnnales de Chirurgie, 2000
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyThe New England Journal of Medicine, 1998
- Sentinel Lymph Node Biopsy in Breast Cancer: Initial Experience at Memorial Sloan-Kettering Cancer CenterJournal of the American College of Surgeons, 1998
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probeSurgical Oncology, 1993
- ROC Methodology in Radiologic ImagingInvestigative Radiology, 1986